BRIEF published on 07/24/2025 at 14:16, 8 months 23 days ago FUTRUE GmbH Proposes Squeeze-Out for PharmaSGP Minority Shareholders Shareholders Compensation Squeeze-out PharmaSGP Futrue GmbH
PRESS RELEASE published on 07/24/2025 at 14:11, 8 months 23 days ago EQS-Adhoc: FUTRUE GmbH submits request to implement squeeze-out of minority shareholders of PharmaSGP Holding SE FUTRUE GmbH requests squeeze-out of minority shareholders by PharmaSGP Holding SE as it holds over 95% shares. Valuation ongoing for cash compensation determination Squeeze-out Minority Shareholders Cash Compensation PharmaSGP Holding SE Futrue GmbH
BRIEF published on 07/18/2025 at 12:02, 8 months 29 days ago PharmaSGP Holding SE Announces Delisting Offer by FUTRUE GmbH Shareholders Healthcare Products Delisting Offer PharmaSGP Futrue GmbH
PRESS RELEASE published on 07/18/2025 at 11:57, 8 months 29 days ago PharmaSGP Holding SE: Acceptance period for FUTRUE GmbH’s public delisting tender offer underway PharmaSGP Holding SE announces FUTRUE GmbH's public delisting tender offer acceptance period. Shareholders can tender shares for €28.00 cash consideration until August 11, 2025 Shareholders Tender Offer Delisting Cash Consideration PharmaSGP Holding SE
BRIEF published on 07/11/2025 at 08:06, 9 months 5 days ago PharmaSGP Holding SE Revises 2025 Revenue Forecast Adjusted EBITDA Revenue Adjustment PharmaSGP 2025 Forecast Geopolitical Uncertainty
PRESS RELEASE published on 07/11/2025 at 08:01, 9 months 5 days ago EQS-Adhoc: PharmaSGP Holding SE adjusts its revenues forecast for the full year 2025 PharmaSGP Holding SE adjusts full year 2025 revenue forecast due to current data evaluation. Adjusted forecast now €132.0-138.0 million. EBITDA expectation maintained EBITDA Revenue Forecast PharmaSGP Holding SE Adjusted Forecast 2025 Fiscal Year
BRIEF published on 06/26/2025 at 12:44, 9 months 20 days ago PharmaSGP Holding SE Holds Annual General Meeting 2025 Financial Results Dividend Policy Annual Meeting PharmaSGP 2025 Forecast
PRESS RELEASE published on 06/26/2025 at 12:39, 9 months 20 days ago PharmaSGP Holding SE holds 2025 Annual General Meeting PharmaSGP Holding SE reports on 2025 Annual General Meeting, with 91.12% share capital represented, €0.05 dividend per share approved, and confirmation of 2025 fiscal year forecast Annual General Meeting Dividend Forecast PharmaSGP Holding SE OTC Pharmaceuticals
BRIEF published on 06/18/2025 at 17:34, 9 months 28 days ago PharmaSGP SE to Redeem Shares Amid Upcoming Delisting Treasury Shares Delisting Squeeze-out Share Redemption PharmaSGP
PRESS RELEASE published on 06/18/2025 at 17:29, 9 months 28 days ago PharmaSGP SE plans to redeem own shares – conditions for squeeze-out under conversion law are met PharmaSGP SE plans to redeem treasury shares to optimize use of new authorization, leading to a squeeze-out possibility due to increased ownership percentage Share Buyback Treasury Shares Squeeze-out PharmaSGP Conversion Law
Published on 04/17/2026 at 02:13, 1 hour 25 minutes ago CHAR Tech annonce l’acquisition projetée d’actifs de biocarbone au Québec, incluant un accord d’achat de 62 500 tonnes, une installation et de la propriété intellectuelle
Published on 04/17/2026 at 02:00, 1 hour 38 minutes ago UraniumX Announces Closing Of Final Tranche Of Non-Brokered Private Placement
Published on 04/16/2026 at 23:32, 4 hours 6 minutes ago Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Published on 04/16/2026 at 21:30, 6 hours 8 minutes ago Organto Foods Expands Financing Facilities with Rabobank
Published on 04/16/2026 at 23:40, 3 hours 58 minutes ago Coventry Ranks #1 in 2025 Life Settlement League Table Report
Published on 04/16/2026 at 21:37, 6 hours 1 minute ago Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.
Published on 04/16/2026 at 21:00, 6 hours 38 minutes ago Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment
Published on 04/16/2026 at 20:35, 7 hours 3 minutes ago EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 8 hours 20 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 18:02, 9 hours 36 minutes ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 17:54, 9 hours 44 minutes ago Aéroports de Paris S.A - March 2026 traffic figures
